Skip to main content
. 2007 Jul 31;19(2):861–868. doi: 10.1007/s10856-007-0166-6

Fig. 2.

Fig. 2

Cellular attachment in the second run. (A) and (B) CaP-coated substrates derived with Electrostatic Spray Deposition (ESD); (C) and (D) non-coated Ti. * indicates a significant difference between the control group and the experimental group with the pre-treatment with anti-integrin-β1 antibodies. # indicates a significant difference between the control group and the experimental group that was pre-treated with anti-integrin-β3 antibodies